Chargement en cours...
Proteomics advances for precision therapy in ovarian cancer
INTRODUCTION: Due to the relatively low mutation rate and high frequency of copy number variation, finding actionable genetic drivers of high grade serous carcinoma (HGSC) is a challenging task. Furthermore, emerging studies show that genetic alterations are frequently poorly represented at the prot...
Enregistré dans:
| Publié dans: | Expert Rev Proteomics |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6814571/ https://ncbi.nlm.nih.gov/pubmed/31512530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14789450.2019.1666004 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|